Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Overview
What you need to judge this in 30 seconds
The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities s
- Category
- R&D
- Industry
- Bio & Healthcare
- Technology
- Needs verification
- Target stage
- Needs verification
- Project duration
- Needs verification
- Estimated preparation
- Needs verification
Funding
Award size and how it is paid
- Award range
- up to $1.5M
- Currency
- USD
- Total programme budget
- Needs verification
- Support type
- Cash
- Co-funding
- None (fully funded)
- Matching fund
- Needs verification
- Disbursement
- Needs verification
- Note
- -
Eligibility
Can we actually apply?
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- RequiredLimited to certain organisation types
Eligibility is restricted to specific organisation types, which may exclude an ordinary company.
- Company age
- Needs verification
- Employees
- Needs verification
- Revenue limits
- Needs verification
- Consortium
- Needs verification
Location Requirements
Geography and legal-entity conditions
- Primary country
- 🇺🇸 United States
- Also eligible
- None
- Foreign companies
- No
- Local entity
- Needs verification
- Location condition
- A US federal programme: the applicant must be an eligible entity based in the United States.
Required Documents
Required/optional · issuer · difficulty · validity · cautions
Document requirements were not captured (needs verification). Check the official announcement.
Application Process
How you apply
Application process not captured.
Evaluation
Review process and criteria
Evaluation process not captured.
Timeline
Announcement → intake → review → agreement → execution
Process steps were not captured.
Equity & Financial Terms
Equity, loans and contract conditions
- Equity required
- Needs verification
- Loan
- Non-dilutive grant
- Duplicate funding
- Needs verification
- IP ownership
- Needs verification
- Deliverable ownership
- Needs verification
- Exclusivity
- Needs verification
- Right of first refusal
- Needs verification
- Audit & settlement
- Needs verification
- Bayh-Dole government licence
US federal R&D funding commonly carries a government licence clause.
Source: Standard across grants.gov federal programmes — check the individual announcement.
Risk Intelligence
Should we apply at all? — five dimensions plus an overall score (lower is safer)
No risk assessment yet. Re-analyse from Admin.
IP / Idea Protection
How much of your technology and idea you must disclose
No IP assessment yet.
AI Analysis
Pros · cons · difficulty · competition · attractiveness
From paperwork and review stages
Heuristic from award size and type
Amount, terms and IP combined
Weighted average of five dimensions
- Needs verification
- Needs verification
- Nothing flagged
Similar Programs
Comparable by type, country and technology
- Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
🇺🇸 United States · Grant · National Institutes of Health
up to $1.5MD-45 - Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-47 - Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-64 - Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-64 - PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
🇺🇸 United States · Grant · National Institutes of Health
Needs verificationD-64
Source & Provenance
Every value carries its source URL and fetch time
- Application URL
- https://www.grants.gov/search-results-detail/357529
- Last fetched
- 2026.08.16
- Human review
- Not reviewed — check the official announcement
- First seen
- 2026.08.16
- Data status
- Auto-collected, not reviewed
- AI enrichment
- Needs verification
- PRIMARYGrants.gov PAR-25-297
Fetched 3h ago
- OFFICIAL_APIGrants.gov Search2 API
Fetched 3h ago
- · 3h ago — 최초 수집 (32e928eb)